WuXi Biologics: Holiday Fire Sale For Leading CRDMO

News Snapshot:

traffic_analyzer Introduction WuXi Biologics (Cayman) Inc. (OTCPK:WXXWY) is one of the world's largest contract-based drug developers. With services falling under common acronyms such as CDMO, CMO, CRDMO, and more, WuXi provides a full-spectrum approach to biologic therapy Research, Development, and Manufacture. While WuXi is undoubtedly one of China's best-performing companies and is financially competitive against other top-tier global investments, recent share price performance has lagged. The geopolitical risks and volatile industry do harm share price performance, but I believe these have led to a gift in this holiday season. All that was needed was one business update that highlighted the...